Global Prostate Cancer Drugs Sales Market Report Forecast 2017-2021

May 2017 | 127 pages | ID: G4A1D74D7D5EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 PROSTATE CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Classification of Prostate Cancer Drugs
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Prostate Cancer Drugs
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Prostate Cancer Drugs Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Prostate Cancer Drugs (2012-2021)
  1.5.1 Global Prostate Cancer Drugs Sales and Growth Rate (2012-2021)
  1.5.2 Global Prostate Cancer Drugs Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON PROSTATE CANCER DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 PROSTATE CANCER DRUGS MANUFACTURING COST ANALYSIS

3.1 Prostate Cancer Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Prostate Cancer Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Prostate Cancer Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL PROSTATE CANCER DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Prostate Cancer Drugs Market Competition by Manufacturers
  5.1.1 Global Prostate Cancer Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Prostate Cancer Drugs Revenue and Share by Manufacturers (2012-2017)
5.2 Global Prostate Cancer Drugs (Volume and Value) by Type
  5.5.1 Global Prostate Cancer Drugs Sales and Market Share by Type (2012-2017)
  5.5.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Prostate Cancer Drugs (Volume and Value) by Regions
  5.3.1 Global Prostate Cancer Drugs Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Prostate Cancer Drugs Revenue and Market Share by Regions (2012-2017)
5.4 Global Prostate Cancer Drugs (Volume) by Application

6 UNITED STATES PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Prostate Cancer Drugs Sales and Value (2012-2017)
  6.1.1 United States Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
  6.1.2 United States Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 United States Prostate Cancer Drugs Sales Price Trend (2012-2017)
6.2 United States Prostate Cancer Drugs Sales and Market Share by Manufacturers
6.3 United States Prostate Cancer Drugs Sales and Market Share by Type
6.4 United States Prostate Cancer Drugs Sales and Market Share by Application

7 CHINA PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 China Prostate Cancer Drugs Sales and Value (2012-2017)
  7.1.1 China Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
  7.1.2 China Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 China Prostate Cancer Drugs Sales Price Trend (2012-2017)
7.2 China Prostate Cancer Drugs Sales and Market Share by Manufacturers
7.3 China Prostate Cancer Drugs Sales and Market Share by Type
7.4 China Prostate Cancer Drugs Sales and Market Share by Application

8 EUROPE PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Prostate Cancer Drugs Sales and Value (2012-2017)
  8.1.1 Europe Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
  8.1.2 Europe Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Prostate Cancer Drugs Sales Price Trend (2012-2017)
8.2 Europe Prostate Cancer Drugs Sales and Market Share by Manufacturers
8.3 Europe Prostate Cancer Drugs Sales and Market Share by Type
8.4 Europe Prostate Cancer Drugs Sales and Market Share by Application

9 JAPAN PROSTATE CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Prostate Cancer Drugs Sales and Value (2012-2017)
  9.1.1 Japan Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Japan Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Prostate Cancer Drugs Sales Price Trend (2012-2017)
9.2 Japan Prostate Cancer Drugs Sales and Market Share by Manufacturers
9.3 Japan Prostate Cancer Drugs Sales and Market Share by Type
9.4 Japan Prostate Cancer Drugs Sales and Market Share by Application

10 GLOBAL PROSTATE CANCER DRUGS MANUFACTURERS ANALYSIS

10.1 Bristol-Myers Squibb
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 AstraZeneca
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Eli Lilly
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Roche
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 GSK
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Novartis
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Pfizer
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Sanofi
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Bayer
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL PROSTATE CANCER DRUGS MARKET FORECAST (2017-2021)

13.1 Global Prostate Cancer Drugs Sales, Revenue Forecast (2017-2021)
13.2 Global Prostate Cancer Drugs Sales Forecast by Regions (2017-2021)
13.3 Global Prostate Cancer Drugs Sales Forecast by Type (2017-2021)
13.4 Global Prostate Cancer Drugs Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Drugs
Table Classification of Prostate Cancer Drugs
Figure Global Sales Market Share of Prostate Cancer Drugs by Type in 2015
Table Applications of Prostate Cancer Drugs
Figure Global Sales Market Share of Prostate Cancer Drugs by Application in 2015
Figure United States Prostate Cancer Drugs Revenue and Growth Rate (2012-2021)
Figure China Prostate Cancer Drugs Revenue and Growth Rate (2012-2021)
Figure Europe Prostate Cancer Drugs Revenue and Growth Rate (2012-2021)
Figure Japan Prostate Cancer Drugs Revenue and Growth Rate (2012-2021)
Figure Global Prostate Cancer Drugs Sales and Growth Rate (2012-2021)
Figure Global Prostate Cancer Drugs Revenue and Growth Rate (2012-2021)
Table Global Prostate Cancer Drugs Sales of Key Manufacturers (2012-2017)
Table Global Prostate Cancer Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Prostate Cancer Drugs Sales Share by Manufacturers
Figure 2016 Prostate Cancer Drugs Sales Share by Manufacturers
Table Global Prostate Cancer Drugs Revenue by Manufacturers (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2016 Global Prostate Cancer Drugs Revenue Share by Manufacturers
Table Global Prostate Cancer Drugs Sales and Market Share by Type (2012-2017)
Table Global Prostate Cancer Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Prostate Cancer Drugs by Type (2012-2017)
Figure Global Prostate Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table Global Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostate Cancer Drugs by Type (2012-2017)
Figure Global Prostate Cancer Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Prostate Cancer Drugs Sales and Market Share by Regions (2012-2017)
Table Global Prostate Cancer Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Prostate Cancer Drugs by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Prostate Cancer Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Prostate Cancer Drugs by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Prostate Cancer Drugs Sales and Market Share by Application (2012-2017)
Table Global Prostate Cancer Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Prostate Cancer Drugs by Application (2012-2017)
Figure Global Prostate Cancer Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
Figure United States Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
Figure United States Prostate Cancer Drugs Sales Price Trend (2012-2017)
Table United States Prostate Cancer Drugs Sales by Manufacturers (2012-2017)
Table United States Prostate Cancer Drugs Market Share by Manufacturers (2012-2017)
Table United States Prostate Cancer Drugs Sales by Type (2012-2017)
Table United States Prostate Cancer Drugs Market Share by Type (2012-2017)
Table United States Prostate Cancer Drugs Sales by Application (2012-2017)
Table United States Prostate Cancer Drugs Market Share by Application (2012-2017)
Figure China Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
Figure China Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
Figure China Prostate Cancer Drugs Sales Price Trend (2012-2017)
Table China Prostate Cancer Drugs Sales by Manufacturers (2012-2017)
Table China Prostate Cancer Drugs Market Share by Manufacturers (2012-2017)
Table China Prostate Cancer Drugs Sales by Type (2012-2017)
Table China Prostate Cancer Drugs Market Share by Type (2012-2017)
Table China Prostate Cancer Drugs Sales by Application (2012-2017)
Table China Prostate Cancer Drugs Market Share by Application (2012-2017)
Figure Europe Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
Figure Europe Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Prostate Cancer Drugs Sales Price Trend (2012-2017)
Table Europe Prostate Cancer Drugs Sales by Manufacturers (2012-2017)
Table Europe Prostate Cancer Drugs Market Share by Manufacturers (2012-2017)
Table Europe Prostate Cancer Drugs Sales by Type (2012-2017)
Table Europe Prostate Cancer Drugs Market Share by Type (2012-2017)
Table Europe Prostate Cancer Drugs Sales by Application (2012-2017)
Table Europe Prostate Cancer Drugs Market Share by Application (2012-2017)
Figure Japan Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
Figure Japan Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Prostate Cancer Drugs Sales Price Trend (2012-2017)
Table Japan Prostate Cancer Drugs Sales by Manufacturers (2012-2017)
Table Japan Prostate Cancer Drugs Market Share by Manufacturers (2012-2017)
Table Japan Prostate Cancer Drugs Sales by Type (2012-2017)
Table Japan Prostate Cancer Drugs Market Share by Type (2012-2017)
Table Japan Prostate Cancer Drugs Sales by Application (2012-2017)
Table Japan Prostate Cancer Drugs Market Share by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Prostate Cancer Drugs Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Prostate Cancer Drugs Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Prostate Cancer Drugs Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Prostate Cancer Drugs Global Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Prostate Cancer Drugs Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Prostate Cancer Drugs Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Prostate Cancer Drugs Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Prostate Cancer Drugs Global Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Prostate Cancer Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure Global Prostate Cancer Drugs Sales and Growth Rate Forecast (2017-2021)
Figure Global Prostate Cancer Drugs Revenue and Growth Rate Forecast (2017-2021)
Table Global Prostate Cancer Drugs Sales Forecast by Regions (2017-2021)
Table Global Prostate Cancer Drugs Sales Forecast by Type (2017-2021)
Table Global Prostate Cancer Drugs Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene